ESR1 and breast carcinoma: For patients with the TNBC subtype, which accounts for ~ 15–20% of breast cancer, a high prevalence of metastasis and poor survival correlate with the lack of hormone receptors ERα, progesterone receptor (PR) and HER2 [6, 7].